Dr. Vatche Garen Agopian, MD

Dr. Agopian practices at Ronald Reagan UCLA Medical Center in Los Angeles, California, part of University of California Health.

Dr. Agopian's NPI, 1720103229, was assigned on March 21, 2007. Dr. Agopian graduated from Vagelos College of Physicians and Surgeons in 2003. Dr. Agopian holds California license A91885.

Dr. Agopian's primary practice is Ronald Reagan UCLA Medical Center, at 757 Westwood Plaza, Los Angeles, CA 90095 in Los Angeles County. The practice phone is (310) 825-6301.

Dr. Agopian's primary practice is Ronald Reagan UCLA Medical Center in Los Angeles, California, part of University of California Health. Dr. Agopian is also affiliated with Hoag Hospital Newport Beach. The medical group on file is UCLA Medical Group. Dmand AI also links Dr. Agopian to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Agopian practices, 2 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Agopian's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dr. Agopian is board certified in general surgery by the American Board of Surgery. Dr. Agopian is licensed in California.

CMS data shows 780 Medicare services from Dr. Agopian across 7 procedure codes in 2024, for 194 Medicare patients. Medicare paid $79,734 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 194 Medicare patients who saw Dr. Agopian in 2024. The largest group is 65 to 74, with 99 patients. 75% of them have high blood pressure, and 68% have high cholesterol. 61% are also on Medicaid. Their average risk score is 3.78, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Agopian's median patient age at 58, with 41% women.

In 2024, Dr. Agopian wrote 13 Medicare Part D claims. 100% of them were for generic drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Dr. Agopian for performance year 2024, reported as part of a group. Dr. Agopian accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Agopian as offering telehealth.

Dmand AI links 76 papers to Dr. Agopian, published from 2009 to 2025. 2021 was the busiest year, with 10. The most frequent topics are Liver Neoplasms, Carcinoma, Hepatocellular and Liver Transplantation. Dr. Agopian has published most often in Hepatology. Dr. Agopian's most frequent co-authors are Fady Michael Kaldas, MD, Douglas G. Farmer, MD and Karim Jarir Halazun, MD.

Dmand AI links Dr. Agopian to 2 clinical trials. Conditions studied include Carcinoma, Hepatocellular, End Stage Liver Disease and Liver Failure.

CMS Open Payments shows 34 general payments to Dr. Agopian from 11 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 55% of the total. Intuitive Surgical, Inc. paid the most, $5,346.

Dmand AI lists 2 awards for Dr. Agopian, most recently ASTS Rising Star in Transplantation Award in 2018.

Dr. Agopian graduated from Vagelos College of Physicians and Surgeons in 2003. Dr. Agopian is a member of AOA, American Society of Transplantation (AST), American Society of Transplant Surgeons, International Liver Cancer Association (ILCA), International Liver Transplantation Society and Pacific Coast Surgical Association (PCSA).

Dr. Agopian is in network with 15 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.